I. G. P. B. Pambudi, I. Suryana, I. Rai, I. Kusumawardani, N. W. Candrawati, I. Sajinadiyasa, N. L. E. Arisanti
{"title":"高中性粒细胞/淋巴细胞比、c反应蛋白、降钙素原和d -二聚体是重症COVID-19的危险因素","authors":"I. G. P. B. Pambudi, I. Suryana, I. Rai, I. Kusumawardani, N. W. Candrawati, I. Sajinadiyasa, N. L. E. Arisanti","doi":"10.37506/mlu.v22i1.3178","DOIUrl":null,"url":null,"abstract":"Background: COVID-19 is caused by the SARS-CoV2 virus which is a new type of virus that causes global morbidity and mortality. Several studies are needed to determine biomarkers to identify the severity of COVID-19. Objective: to analyze the correlation between Neutrophil to lymphocyte rate (NLR), C-Reactive Protein (CRP), D-dimer, dan Procalcitonin (PCT) on the severity of COVID-19. Method: A retrospective case-control study was done in our institution using data from June 2020 to March 2021. Data collected were serum NLR, CRP, d-dimer and PCT. Data were analysed using SPSS. Participants were divided into 2 groups, severe COVID-19 as case and mild to moderate as control group. The data collection was carried out in June 2020 – March 2021, included NLR, CRP, D-dimer, and PCT in patient serum. Data analysis using Chi-Square test and logistic regression with p < 0.05. Result: The NLR value of participants in case group is 11.4 ± 9.7 and in control group is 8.2 ± 8.5 (95% CI 1.081 – 4.641;p = 0.023). The PCT value of participants in case group was 10.3 ± 75.4 and in control group was 6.9 ± 41.4 (95% CI 1.495 – 6.908;p < 0.001). CRP values in case group (123.7 ± 108.9) were higher than control group (61.3 ± 60.8;95% CI 1.181 – 5.063;p < 0.001). Meanwhile, the value of D-dimer participants in case group was 3.5 ± 3.7 and control group was 2.7 ± 4.6 (95% CI 0.604 – 2.958;p = 0.473). Conclusion: increased values of NLR, CRP, and D-dimer are risk factors for severe COVID-19.","PeriodicalId":18400,"journal":{"name":"Medico-Legal Update","volume":"66 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"High Neutrophil to Lymphocyte Ratio, C-Reactive Protein, Procalcitonin and D-dimer as Risk Factors for Severe COVID-19\",\"authors\":\"I. G. P. B. Pambudi, I. Suryana, I. Rai, I. Kusumawardani, N. W. Candrawati, I. Sajinadiyasa, N. L. E. Arisanti\",\"doi\":\"10.37506/mlu.v22i1.3178\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: COVID-19 is caused by the SARS-CoV2 virus which is a new type of virus that causes global morbidity and mortality. Several studies are needed to determine biomarkers to identify the severity of COVID-19. Objective: to analyze the correlation between Neutrophil to lymphocyte rate (NLR), C-Reactive Protein (CRP), D-dimer, dan Procalcitonin (PCT) on the severity of COVID-19. Method: A retrospective case-control study was done in our institution using data from June 2020 to March 2021. Data collected were serum NLR, CRP, d-dimer and PCT. Data were analysed using SPSS. Participants were divided into 2 groups, severe COVID-19 as case and mild to moderate as control group. The data collection was carried out in June 2020 – March 2021, included NLR, CRP, D-dimer, and PCT in patient serum. Data analysis using Chi-Square test and logistic regression with p < 0.05. Result: The NLR value of participants in case group is 11.4 ± 9.7 and in control group is 8.2 ± 8.5 (95% CI 1.081 – 4.641;p = 0.023). The PCT value of participants in case group was 10.3 ± 75.4 and in control group was 6.9 ± 41.4 (95% CI 1.495 – 6.908;p < 0.001). CRP values in case group (123.7 ± 108.9) were higher than control group (61.3 ± 60.8;95% CI 1.181 – 5.063;p < 0.001). Meanwhile, the value of D-dimer participants in case group was 3.5 ± 3.7 and control group was 2.7 ± 4.6 (95% CI 0.604 – 2.958;p = 0.473). Conclusion: increased values of NLR, CRP, and D-dimer are risk factors for severe COVID-19.\",\"PeriodicalId\":18400,\"journal\":{\"name\":\"Medico-Legal Update\",\"volume\":\"66 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medico-Legal Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37506/mlu.v22i1.3178\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medico-Legal Update","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37506/mlu.v22i1.3178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
摘要
背景:COVID-19是由SARS-CoV2病毒引起的,SARS-CoV2病毒是一种引起全球发病率和死亡率的新型病毒。需要进行几项研究来确定生物标志物,以确定COVID-19的严重程度。目的:分析中性粒细胞对淋巴细胞率(NLR)、c反应蛋白(CRP)、d -二聚体、降钙素原(PCT)与COVID-19严重程度的相关性。方法:采用2020年6月至2021年3月在我院进行回顾性病例对照研究。收集的数据为血清NLR、CRP、d-二聚体、PCT,数据采用SPSS统计软件进行分析。参与者分为2组,重症为病例,轻至中度为对照组。数据收集于2020年6月至2021年3月进行,包括患者血清中的NLR、CRP、d -二聚体和PCT。数据分析采用卡方检验和logistic回归,p < 0.05。结果:病例组NLR值为11.4±9.7,对照组为8.2±8.5 (95% CI 1.081 ~ 4.641;p = 0.023)。病例组PCT值为10.3±75.4,对照组PCT值为6.9±41.4 (95% CI 1.495 ~ 6.908;p < 0.001)。病例组CRP值(123.7±108.9)高于对照组(61.3±60.8),95% CI 1.181 ~ 5.063, p < 0.001)。同时,病例组的d -二聚体评分为3.5±3.7,对照组为2.7±4.6 (95% CI 0.604 ~ 2.958;p = 0.473)。结论:NLR、CRP、d -二聚体升高是重症COVID-19的危险因素。
High Neutrophil to Lymphocyte Ratio, C-Reactive Protein, Procalcitonin and D-dimer as Risk Factors for Severe COVID-19
Background: COVID-19 is caused by the SARS-CoV2 virus which is a new type of virus that causes global morbidity and mortality. Several studies are needed to determine biomarkers to identify the severity of COVID-19. Objective: to analyze the correlation between Neutrophil to lymphocyte rate (NLR), C-Reactive Protein (CRP), D-dimer, dan Procalcitonin (PCT) on the severity of COVID-19. Method: A retrospective case-control study was done in our institution using data from June 2020 to March 2021. Data collected were serum NLR, CRP, d-dimer and PCT. Data were analysed using SPSS. Participants were divided into 2 groups, severe COVID-19 as case and mild to moderate as control group. The data collection was carried out in June 2020 – March 2021, included NLR, CRP, D-dimer, and PCT in patient serum. Data analysis using Chi-Square test and logistic regression with p < 0.05. Result: The NLR value of participants in case group is 11.4 ± 9.7 and in control group is 8.2 ± 8.5 (95% CI 1.081 – 4.641;p = 0.023). The PCT value of participants in case group was 10.3 ± 75.4 and in control group was 6.9 ± 41.4 (95% CI 1.495 – 6.908;p < 0.001). CRP values in case group (123.7 ± 108.9) were higher than control group (61.3 ± 60.8;95% CI 1.181 – 5.063;p < 0.001). Meanwhile, the value of D-dimer participants in case group was 3.5 ± 3.7 and control group was 2.7 ± 4.6 (95% CI 0.604 – 2.958;p = 0.473). Conclusion: increased values of NLR, CRP, and D-dimer are risk factors for severe COVID-19.